TC BioPharm (Holdings) plc (Stock Symbol: TCBPY)
is a leading company in the Life Sciences sector
, specifically operating within the Biological Products, (No Diagnostic Substances) industry.
.
The company has established itself as
an emerging investment opportunity with substantial growth potential.
Financial Performance & Key Metrics Analysis
Market Capitalization: $21 million - Classified as a
small-cap investment offering high growth potential.
Advanced AI Stock Prediction & Price Target Analysis
🚀 Unlock Premium AI Predictions to access our advanced machine learning forecasts for TC BioPharm (Holdings) plc stock, including 7-day, 30-day, and 90-day price targets with confidence intervals and risk assessments.
Market Position & Competitive Advantage Analysis
TC BioPharm (Holdings) plc strategically competes in the highly dynamic
Biological Products, (No Diagnostic Substances) marketplace,
representing an emerging small-cap investment with substantial growth potential and market disruption capabilities
.
.
TC BioPharm (Holdings) plc Stock Price Chart and Technical Analysis
Deep dive into TC BioPharm (Holdings) plc's financial health, valuation metrics, and operational efficiency to make informed investment decisions.
Understanding Valuation Metrics
What these metrics mean: Valuation metrics help determine if TC BioPharm (Holdings) plc stock is fairly priced compared to its earnings, assets, and market position.
How to read them: Lower P/E ratios may indicate undervalued stocks, while higher ratios suggest growth expectations. P/B ratio compares market value to book value.
For TC BioPharm (Holdings) plc:
P/B Ratio19.10x
Market Cap$21M
Book Value/Share$0.02
Understanding Profitability Metrics
What these metrics mean: These ratios measure how efficiently TC BioPharm (Holdings) plc converts revenue into profit and generates returns for shareholders.
How to read them: Higher ROE/ROA indicate better management efficiency. Margin percentages show profit at different operational levels.
For TC BioPharm (Holdings) plc:
Understanding Financial Health Metrics
What these metrics mean: These ratios assess TC BioPharm (Holdings) plc's ability to meet short-term obligations and manage debt levels effectively.
How to read them: Current ratio >2 is generally good, Quick ratio >1 shows strong liquidity. Lower D/E ratios indicate conservative debt management.
For TC BioPharm (Holdings) plc:
Understanding Cash Flow Metrics
What these metrics mean: Cash flow metrics reveal TC BioPharm (Holdings) plc's ability to generate cash from operations and fund growth initiatives.
How to read them: Positive operating cash flow is crucial. Free cash flow shows money available for dividends, buybacks, or investments.
For TC BioPharm (Holdings) plc:
Understanding Operational Efficiency Metrics
What these metrics mean: These ratios measure how effectively TC BioPharm (Holdings) plc uses its assets and manages working capital.
How to read them: Higher turnover ratios indicate efficient asset utilization. Shorter collection periods show effective credit management.
For TC BioPharm (Holdings) plc:
Understanding Financial Statement Data
What these metrics mean: Key figures from TC BioPharm (Holdings) plc's income statement and balance sheet showing absolute financial performance.
How to read them: Revenue shows business scale, while margins indicate profitability. Balance sheet items reveal financial structure.
For TC BioPharm (Holdings) plc:
Income Statement ($ Millions)
Net Income$-13M
Balance Sheet Highlights ($ Millions)
Dividend & Shareholder Information
Shares Outstanding64M
TC BioPharm (Holdings) plc (TCBPY) Fundamental Analysis & Insider Trading Data
(Quarterly Financial Reports)
Comprehensive quarterly financial data, earnings trends, insider transactions, and institutional holdings for TC BioPharm (Holdings) plc stock analysis.
Loading fundamental data...
Loading TC BioPharm (Holdings) plc comprehensive fundamental analysis and insider trading data...
A look at the shareholders of TC Biopharm (Holdings) Plc (NASDAQ:TCBP) can tell us which group is most powerful. We can see that individual investors own the lion's share in the company with 51% ...
TC Biopharm (Holdings) Plc, a clinical-stage biopharmaceutical company, focuses on the development of immunotherapy products based on its allogeneic gamma delta T cell platform. Its product pipeline ...
TC Biopharm Provides Update on Acquisition Strategy and Current Targets TC BioPharm (Holdings) PLC (TCBP) a clinical-stage biotechnology company developing platform allogeneic gamma-delta T-cell ...
TC Biopharm (Holdings) PLC chart This market's chart. This is a visual representation of the price action in the market, over a certain period of time. You can use this to help gauge a market’s ...
The conference will take place Jan. 21-23, 2025, at the Condado Vanderbilt Hotel in San Juan, Puerto Rico. To view the full press release, visit: About TC BioPharm Holdings PLC ...
A look at the shareholders of TC Biopharm (Holdings) Plc (NASDAQ:TCBP) can tell us which group is most powerful. We can see that individual investors own the lion's share in the company with 51% ...
TC BioPharm reports progress in AML treatment trial EDINBURGH, Scotland - TC BioPharm (Holdings) PLC (NASDAQ: TCBP), a biotechnology firm with a market capitalization of $33.08 ...
TC BioPharm is a clinical stage biopharmaceutical company focused on the discovery, development and commercialization of gamma-delta T cell therapies for the treatment of cancer with human ...
Comparative analysis of TC BioPharm (Holdings) plc against industry peers and competitors in the Life Sciences sector, featuring AI-powered forecasts and key financial metrics.
How accurate are TC BioPharm (Holdings) plc stock predictions?
Our AI model demonstrates 19% historical accuracy for TCBPY predictions, based on advanced machine learning algorithms trained on over 10 years of market data.
What factors influence TC BioPharm (Holdings) plc stock price forecasts?
Is TC BioPharm (Holdings) plc a good investment in 2025?
Based on our AI analysis, TC BioPharm (Holdings) plc shows potential for various market scenarios. Consider your risk tolerance, investment timeline, and portfolio diversification before making investment decisions.
How often are TC BioPharm (Holdings) plc forecasts updated?
TC BioPharm (Holdings) plc stock forecasts are updated daily using real-time market data, ensuring you receive the most current AI-powered predictions and investment insights.
Want More Advanced TC BioPharm (Holdings) plc Analysis?
Unlock premium features including detailed price targets, risk assessments, portfolio optimization, and real-time alerts for TC BioPharm (Holdings) plc stock.
